Arcadia Biosciences (RKDA) to Release Earnings on Tuesday

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) is set to announce its earnings results after the market closes on Tuesday, November 12th. Analysts expect Arcadia Biosciences to post earnings of ($0.77) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The basic materials company reported $0.78 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.27 by ($0.49). Arcadia Biosciences had a negative return on equity of 57.51% and a negative net margin of 127.29%. The company had revenue of $1.31 million during the quarter, compared to the consensus estimate of $0.95 million. During the same quarter in the prior year, the business earned ($2.64) earnings per share. On average, analysts expect Arcadia Biosciences to post $-2 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Arcadia Biosciences Stock Performance

RKDA stock traded down $0.06 during mid-day trading on Tuesday, reaching $3.85. 2,609 shares of the stock traded hands, compared to its average volume of 18,758. Arcadia Biosciences has a one year low of $1.85 and a one year high of $5.34. The stock has a market capitalization of $5.25 million, a PE ratio of -0.78 and a beta of 1.27. The business has a 50-day moving average price of $3.15 and a two-hundred day moving average price of $2.91.

Analysts Set New Price Targets

Several brokerages recently commented on RKDA. StockNews.com assumed coverage on shares of Arcadia Biosciences in a report on Wednesday, October 30th. They set a “sell” rating on the stock. HC Wainwright reaffirmed a “buy” rating and set a $6.00 target price on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.

Read Our Latest Report on RKDA

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Further Reading

Earnings History for Arcadia Biosciences (NASDAQ:RKDA)

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.